These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12534877)

  • 1. 6-thioguanine: a new old drug to procure remission in inflammatory bowel disease.
    Cheung TK; Florin TH
    Intern Med J; 2003; 33(1-2):44-6. PubMed ID: 12534877
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
    Almer SH; Hjortswang H; Hindorf U
    Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease.
    Qasim A; McDonald S; Sebastian S; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Scand J Gastroenterol; 2007 Feb; 42(2):194-9. PubMed ID: 17327939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission maintenance by tioguanine in chronic active Crohn's disease.
    Herrlinger KR; Deibert P; Schwab M; Kreisel W; Fischer C; Fellermann K; Stange EF
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1459-64. PubMed ID: 12823147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease.
    Rulyak SJ; Saunders MD; Lee SD
    J Clin Gastroenterol; 2003 Mar; 36(3):234-7. PubMed ID: 12590235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Reported Experiences with a Relicensed Generic: Thioguanine for the Treatment of Inflammatory Bowel Diseases.
    Simsek M; Markus-de Kwaadsteniet TML; van der Horst D; Mulder CJJ; de Boer NKH
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):385-389. PubMed ID: 30574620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further experience with the use of 6-thioguanine in patients with Crohn's disease.
    Ansari A; Elliott T; Fong F; Arenas-Hernandez M; Rottenberg G; Portmann B; Lucas S; Marinaki A; Sanderson J
    Inflamm Bowel Dis; 2008 Oct; 14(10):1399-405. PubMed ID: 18521912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
    Herrlinger KR; Fellermann K; Fischer C; Kreisel W; Deibert P; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Greinwald R; Stange EF; Schwab M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1269-76. PubMed ID: 15191508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Thioguanine: a naked bullet? (Or how pharmacogenomics can make old drugs brand new).
    Baert F; Rutgeerts P
    Inflamm Bowel Dis; 2001 Aug; 7(3):190-1. PubMed ID: 11515843
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a role for thioguanine therapy in IBD in 2017 and beyond?
    Taylor KM; Ward MG; Blaker PA; Sparrow MP
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):473-486. PubMed ID: 28276819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continued development of drugs: the path of thioguanine].
    Simsek M; de Boer NKH; Mulder CJJ
    Ned Tijdschr Geneeskd; 2018; 162():D1757. PubMed ID: 29350120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.
    Dubinsky MC; Hassard PV; Seidman EG; Kam LY; Abreu MT; Targan SR; Vasiliauskas EA
    Inflamm Bowel Dis; 2001 Aug; 7(3):181-9. PubMed ID: 11515842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B; Boitard J; Marteau P; Lémann M; Coffin B; Flourié B; Belaiche J; Cadiot G; Metman EH; Cortot A; Colombel JF;
    Aliment Pharmacol Ther; 2003 Aug; 18(4):401-8. PubMed ID: 12940925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.
    Wright S; Sanders DS; Lobo AJ; Lennard L
    Gut; 2004 Aug; 53(8):1123-8. PubMed ID: 15247179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine.
    de Jong D; Mulder CJ; van Sorge AA
    Gut; 2001 Dec; 49(6):874. PubMed ID: 11758505
    [No Abstract]   [Full Text] [Related]  

  • 16. On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.
    de Boer NK; de Graaf P; Wilhelm AJ; Mulder CJ; van Bodegraven AA
    Aliment Pharmacol Ther; 2005 Sep; 22(5):447-51. PubMed ID: 16128683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease.
    Kane S; Cohen SM; Hart J
    Inflamm Bowel Dis; 2004 Sep; 10(5):652-4. PubMed ID: 15472529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-MP metabolite levels: a potential guide to Crohn's disease therapy.
    Sandborn WJ
    Gastroenterology; 1997 Aug; 113(2):690-2. PubMed ID: 9247497
    [No Abstract]   [Full Text] [Related]  

  • 19. Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.
    Pavlidis P; Ansari A; Duley J; Oancea I; Florin T
    Inflamm Bowel Dis; 2014 Dec; 20(12):2239-46. PubMed ID: 25230165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited intra-individual variability in hypoxanthine-Guanine phosphoribosyl transferase, thiopurine S-methyl transferase, and xanthine oxidase activity in inflammatory bowel disease patients during 6-thioguanine therapy.
    van Asseldonk DP; de Boer NK; Smid K; Mulder CJ; van Bodegraven AA; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):284-90. PubMed ID: 20544508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.